from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0660c/mazE2

LFCtreatmentdescriptionclass of inhibitor

0.031

Amikacinug/mL Amikacintranslation

0.002

Cap5-10ug/mL Capreomycintranslation

-0.462

Rox10-50 ug/mL Roxithromycintranslation

0.052

SM2-5 ug/mL Streptomycintranslation

0.908

Tet5-10 ug/mL Tetracyclinetranslation

-0.925

Rif0.2-5ug/mL Rifampicintranscription

-1.393

Rifp0.1-0.5ug/mL Rifapentinetranscription

-3.045

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.470

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.219

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.629

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.739

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.722

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.535

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.763

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.414

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.317

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.054

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.334

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.096

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.071

KCN5-20 ug/mL Potassium cyaniderespiration

0.449

NaN30.2-2 mM Sodium aziderespiration

-1.155

Nigericin50 uM Nigericinrespiration

-1.097

TRC10-150 ug/mL Triclosanrespiration

-0.409

TRZ10-25 ug/mL Thioridazinerespiration

-0.943

Valinomycin0.5-10 uM Valinomycinrespiration

-0.413

ZnSO42 mM ZnSO4respiration

-0.397

menadione6-10 ug/mL Menadionerespiration

-0.291

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.131

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.347

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.157

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.041

NRP_1Non-replicating persistence stage 1dosRassociated

0.673

Amp0.2mg/mL AmpicillincellWall

0.642

Cephalexin20-100 ug/mL CephalexincellWall

0.259

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.079

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.323

EMB10-20 ug/mL EthambutolcellWall

1.416

Eta12-40 ug/mL EthionamidecellWall

1.957

INH0.2-0.4 ug/mL IsoniazidcellWall

0.299

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.458

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.334

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.040

BZA0.12 mg/mL BenzamidearomaticAmides

0.553

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.232

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-1.386

H2O24 mM hydrogen peroxideDNAdamaging

-0.377

Levo10 ug/mL LevofloxacinDNAdamaging

-0.235

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.703

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.442

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.120

UVUV-irradiationDNAdamaging

-2.051

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.435

Antimycin12.5-50 ug/mL Antimycin A?

-0.127

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.307

PA_110-50 ug/mL Antitubercular compound PA-1?

0.446

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.865

PA8240.2-2 ug/mL PA-824?

1.031

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.216

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.090

Verapamil50 uM Verapamil?

-0.650

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.404

methoxatin10-20 ug/mL Methoxatin?